BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33048426)

  • 1. TET2: A cornerstone in normal and malignant hematopoiesis.
    Kunimoto H; Nakajima H
    Cancer Sci; 2021 Jan; 112(1):31-40. PubMed ID: 33048426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
    Nakajima H; Kunimoto H
    Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation.
    An J; Ko M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
    Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
    Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.
    Joshi K; Zhang L; Breslin S J P; Kini AR; Zhang J
    J Exp Clin Cancer Res; 2022 Oct; 41(1):294. PubMed ID: 36203205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation disruption reshapes the hematopoietic differentiation landscape.
    Izzo F; Lee SC; Poran A; Chaligne R; Gaiti F; Gross B; Murali RR; Deochand SD; Ang C; Jones PW; Nam AS; Kim KT; Kothen-Hill S; Schulman RC; Ki M; Lhoumaud P; Skok JA; Viny AD; Levine RL; Kenigsberg E; Abdel-Wahab O; Landau DA
    Nat Genet; 2020 Apr; 52(4):378-387. PubMed ID: 32203468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
    Asmar F; Punj V; Christensen J; Pedersen MT; Pedersen A; Nielsen AB; Hother C; Ralfkiaer U; Brown P; Ralfkiaer E; Helin K; Grønbæk K
    Haematologica; 2013 Dec; 98(12):1912-20. PubMed ID: 23831920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells.
    McClatchy J; Strogantsev R; Wolfe E; Lin HY; Mohammadhosseini M; Davis BA; Eden C; Goldman D; Fleming WH; Conley P; Wu G; Cimmino L; Mohammed H; Agarwal A
    Nat Commun; 2023 Dec; 14(1):8102. PubMed ID: 38062031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis.
    Tulstrup M; Soerensen M; Hansen JW; Gillberg L; Needhamsen M; Kaastrup K; Helin K; Christensen K; Weischenfeldt J; Grønbæk K
    Nat Commun; 2021 Oct; 12(1):6061. PubMed ID: 34663818
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kunimoto H; McKenney AS; Meydan C; Shank K; Nazir A; Rapaport F; Durham B; Garrett-Bakelman FE; Pronier E; Shih AH; Melnick A; Chaudhuri J; Levine RL
    Blood; 2017 Mar; 129(13):1779-1790. PubMed ID: 28077417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation.
    Aivalioti MM; Bartholdy BA; Pradhan K; Bhagat TD; Zintiridou A; Jeong JJ; Thiruthuvanathan VJ; Pujato M; Paranjpe A; Zhang C; Levine RL; Viny AD; Wickrema A; Verma A; Will B
    Blood Cancer Discov; 2022 Sep; 3(5):444-467. PubMed ID: 35820129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STING activation in TET2-mutated hematopoietic stem/progenitor cells contributes to the increased self-renewal and neoplastic transformation.
    Xie J; Sheng M; Rong S; Zhou D; Wang C; Wu W; Huang J; Sun Y; Wang Y; Chen P; Wu Y; Wang Y; Wang L; Zhou BO; Huang X; Walsh CP; Bohlander SK; Huang J; Wang X; Xu GL; Gao H; Shi Y
    Leukemia; 2023 Dec; 37(12):2457-2467. PubMed ID: 37816954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis.
    Rasmussen KD; Jia G; Johansen JV; Pedersen MT; Rapin N; Bagger FO; Porse BT; Bernard OA; Christensen J; Helin K
    Genes Dev; 2015 May; 29(9):910-22. PubMed ID: 25886910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET proteins and 5-methylcytosine oxidation in hematological cancers.
    Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
    Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.
    Yamazaki J; Jelinek J; Lu Y; Cesaroni M; Madzo J; Neumann F; He R; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Kantarjian HM; Liang S; Estecio MR; Godley LA; Issa JP
    Cancer Res; 2015 Jul; 75(14):2833-43. PubMed ID: 25972343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Kunimoto H; Nakajima H
    Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.
    Ko M; Bandukwala HS; An J; Lamperti ED; Thompson EC; Hastie R; Tsangaratou A; Rajewsky K; Koralov SB; Rao A
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14566-71. PubMed ID: 21873190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
    Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
    Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
    Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
    Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking hematopoietic precursor division ex vivo in real time.
    Wang Y; Tian H; Cai W; Lian Z; Bhavanasi D; Wu C; Sato T; Kurokawa M; Wu D; Fu L; Wang H; Shen H; Liang D; Huang J
    Stem Cell Res Ther; 2018 Jan; 9(1):16. PubMed ID: 29361987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.